NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$0.51
-0.11 (-16.95%)
As of Feb 8, 2:29 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +1,545.0% upside
Low Target $5.74
Average Target $8.47
High Target $10.28
Current Price $0.51
Current
$0.51
Target
$8.47
$5.74 $8.47 avg $10.28
Scenario Analysis
Bear Case
$5.74
1,014.8%
Low target
Base Case
$8.47
+1,545.0%
Avg target
Bull Case
$10.28
+1,896.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$9.14
-94.4% from high
52-Week Low
$5.66
+-90.9% from low
Target vs 52W High
$8.47
-7.3% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%